Clinical presentation of PTEN mutations in childhood in the absence of family history of Cowden syndrome

Eur J Paediatr Neurol. 2015 Mar;19(2):188-92. doi: 10.1016/j.ejpn.2014.11.012. Epub 2014 Dec 16.

Abstract

Background: PTEN gene (MIM 601628) is a tumor suppressor gene implicated in PTEN hamartoma tumor syndromes (PHTS) including Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, and Proteus-like syndrome. Bannayan-Riley-Ruvalcaba syndrome is considered as the pediatric form of PHTS. More recently, children presenting autism spectrum disorders with macrocephaly (ASD-M) have been reported.

Methods: We report clinical data from seven patients diagnosed in childhood with a PTEN germline mutation, excluding cases of familial Cowden syndrome.

Results: This study underlines the variability of phenotype associated with PTEN mutations diagnosed at pediatric age. Most of the patients did not fulfill usual criteria of Bannayan-Riley-Ruvalcaba syndrome or ASD-M.

Conclusion: PTEN testing should be considered in any child presenting with severe macrocephaly (>+4SD) and another feature of PHTS.

Keywords: Arteriovenous malformation; Autism spectrum disorder; Bannayan–Riley–Ruvalcaba syndrome; Developmental delay; Macrocephaly; PTEN.

Publication types

  • Case Reports

MeSH terms

  • Autism Spectrum Disorder / etiology
  • Autism Spectrum Disorder / genetics
  • Child
  • Child, Preschool
  • Consanguinity
  • Developmental Disabilities / etiology
  • Developmental Disabilities / genetics
  • Female
  • Hamartoma Syndrome, Multiple / genetics*
  • Hamartoma Syndrome, Multiple / pathology
  • Humans
  • Infant
  • Intracranial Arteriovenous Malformations / complications
  • Intracranial Arteriovenous Malformations / genetics
  • Male
  • Megalencephaly / etiology
  • Megalencephaly / genetics
  • Micronucleus, Germline
  • Mutation / genetics
  • PTEN Phosphohydrolase / genetics*
  • Phenotype

Substances

  • PTEN Phosphohydrolase
  • PTEN protein, human